Immunization and Vaccines for Children Program COVID Cycle 3 and Cycle 4 Supplemental Funding
Frequently Asked Questions
Yes, all COVID supplements issued under IP19-1901 have a budget period through June 30, 2024. This includes COVID/Flu funding awarded in June 2020, and COVID funding awarded in September 2020, December 2020, January 2021, March 2021, and May 2021. To be clear, this language pertains to all document numbers ending in C3, C5, and C6. Therefore, it pertains to 19NH23IP922XXXC3, 20NH23IP922XXXC3, 20NH23IP922XXXC5, 20NH23IP922XXXUDSPC5, 20NH23IP922XXXC6, and 20NH23IP922XXXVWCC6. The document numbers listed will be available for use through June 30, 2024. As with standard funds, the 90-day liquidation period will also apply.
Award recipients may re-budget, or informally redirect, up 25%, of award funding. Informal redirection requests must be submitted to the POB project officer, for review and concurrence, and subsequently uploaded into GrantSolutions as a grant note.
Significant re-budgeting (greater than 25%) of direct cost budget categories requires prior approval. This formal redirection must be submitted into Grant Solutions as a budget revision amendment.
Note, informal redirection requests are cumulative. Please ensure you are tracking re-budgeting shifts. If your program submits multiple informal requests and the total cumulative funding exceeds 25%, then a formal redirection that includes all budget changes must be submitted as a budget revision amendment in Grant Solutions.
Yes. There are several actions which require prior approval. For a complete listing, including the information that must be submitted with each action please review the guidance for CDC Prior Approvals for Non-research Awardspdf iconpdf icon.
IP19-1901 COVID -19 Supplement funding should be the primary source of funding for vaccination activities. Other sources of funding that may support gaps not covered by this supplement include ELC and FEMA Public Assistance. For support in determining if an activity is appropriate for IP19-1901 COVID Supplement funding, please contact your POB Project Officer.
Additional information about the other available funding:
Any person living in the US, regardless of duration, is eligible to be vaccinated. There is no prohibition on vaccinating non-US citizens or non-residents. Everyone, regardless of citizenship, should have access to vaccine and is eligible to be vaccinated.
CDC cooperative agreements were recently modified to state that recipients “must distribute or administer vaccine without discriminating on non-public-health grounds within a prioritized group.”
Most foreign diplomats have health care plans here in the US and they will be vaccinated where they normally get health care and that location [will] can bill the administration fee [costs] to their insurance plan.
The COVID supplement 3 budget that you submit must allocate the entire amount of funding that you have received, but that funding need not take you through 6/30/2024 if you will be able to liquidate those funds earlier.
We want to strongly encourage you to use the funding as quickly as you can in order to accelerate your vaccination activities. Budget formulation and the timeframe of forecasted expenditures should be based on the immediate needs of your organization although the funding is available through 6/30/2024. You are encouraged to forecast your budget as accurately as you can into the future while at the same time making every effort to accelerate your vaccination activities.
There are many ways you may plan to allocate funding through 6/30/2024, as long as funding use is aligned with the goals and purpose of the supplemental funding. Examples of budget categories which might need long-term allocation of funds through 6/30/2024 include (but are not limited to) personnel and contracts.
- Importance of COVID-19 Vaccination for Essential Workers
- Workplace Vaccination Program
- Essential Workers & Employees: When & How to Get Vaccinated
- COVID-19 Vaccine Communication Toolkit for Essential Workers
A crosswalk of allowable expenses for the ELC Enhancing Detection expansion and Immunization cooperative agreement COVID-19 supplements is available online under the “Funding Resources” section of: https://www.cdc.gov/vaccines/covid-19/covid19-vaccination-guidance.html.
The crosswalk is extensive but is not exhaustive. In addition to referencing the ELC and 317/VFC Cooperative Agreement COVID Funding Allowable Expensespdf iconpdf icon document, awardees are also encouraged to consult with their POB Project Officer.
The page limit of 25 pages for the workplan is not a requirement, and workplans may be longer as needed. The page limit is intended to describe that workplans should be succinct and need not be lengthy. However, the workplan should sufficiently describe your activities, and it will not be rejected if longer than 25 pages.
Yes. To fund transportation (public transportation or ride share services) for the public to receive COVID vaccine, submit a plan to your POB Project Officer that covers the following elements: (a) justification, (b) cost savings [e.g., how it will defray costs or have a positive return on investment], (c) defined amount, (d) qualifications for issuance, & (e) method of tracking.
Depending on the transportation company, awardees may also be able to establish interagency agreements with their Department of Transportation or create contracts/MOUs with other appropriate partners and have an established documented reimbursement rate. In this instance travel would be covered on the front end and the awardee would reimburse the company.